HER2-addicted Breast Cancer: Clinical Trials

1 trial for HER2-addicted Breast Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow HER2-addicted Breast Cancer: new trials by email Literature Review of HER2-addicted Breast Cancer trials Research Report on HER2-addicted Breast Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Retifanlimab With Trastuzumab and Pertuzumab Combination in HER2-Addicted Breast Cancer
Retifanlimab, Trastuzumab (Herceptin), Pertuzumab - HER2-addicted Breast Cancer
Phase 2Not yet recruitingPolly A. Niravath, MD302026-12-312026-08-19

Interventions

Trastuzumab (1)  ·  pertuzumab (1)

Sponsors

Polly A. Niravath, MD (1)